EFEarnings Feed

N

Company dossier

NAVIDEA BIOPHARMACEUTICALS, INC.

CIK 0000810509SIC 2835In Vitro & In Vivo Diagnostic Substances

Add to watchlist

Exchange

—

Entity type

operating

Fiscal year end

Dec 31

Headquarters

DE

SEC profile ↗

Recent filings

Latest submissions

6 items

10-QAccepted Nov 11, 7:00 PM ETAcc 0000950152-99-008992
NEOPROBE CORP425.6 KB
NEOPROBE CORP 10-Q
View filing
10-QAccepted Aug 15, 8:00 PM ETAcc 0000950152-99-006962
NEOPROBE CORP102.9 KB
NEOPROBE CORP 10-Q
View filing
10-QAccepted May 16, 8:00 PM ETAcc 0000950152-99-004587
NEOPROBE CORP187.3 KB
NEOPROBE CORP 10-Q
View filing
10-KAccepted Mar 30, 7:00 PM ETAcc 0000950128-99-000642
NEOPROBE CORP821.1 KB
NEOPROBE CORP 10-K
View filing
8-KAccepted Dec 7, 7:00 PM ETAcc 0000950152-98-009434
NEOPROBE CORP6.6 KB
NEOPROBE CORP 8-K
View filing
10-QAccepted Nov 15, 7:00 PM ETAcc 0000950152-98-009036
NEOPROBE CORP180.9 KB
NEOPROBE CORP 10-Q
View filing

Monitoring

Insider owner filings: No
Insider issuer filings: Yes
Tickers on record: 0

Ticker roster

No tickers on record.

Addresses

business
4995 BRADENTON AVENUE SUITE 240
DUBLIN, OH, 43017
mailing
4995 BRADENTON AVENUE SUITE 240
DUBLIN, OH, 43017

Former names

NEOPROBE CORP
1995-02-10 – 2011-12-30